Sophiris Bio Inc. Email Format
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
| Sophiris Bio Inc. Email Formats | Percentage |
| FLast@sophirisbio.com | 39% |
| First@sophirisbio.com | 11% |
| FLast@sophirisbio.com | 39% |
| First@sophirisbio.com | 11% |
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company developing topsalysin (PRX302) for the treatment of urological diseases
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.